Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis

MLA

Gregory J. Gores, et al. “Cathepsin B Inactivation Attenuates Hepatic Injury and Fibrosis during Cholestasis.” Journal of Clinical Investigation, vol. 112, July 2003, pp. 152–59. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7f1d49c2cc149fc8566845b257fca33&authtype=sso&custid=ns315887.

APA

Gregory J. Gores, Maria Eugenia Guicciardi, Steven F. Bronk, Ariel E. Feldstein, Ali Canbay, Makiko Tanai, Hajime Higuchi, & Robert M. Rydzewski. (2003). Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. Journal of Clinical Investigation, 112, 152–159.

Chicago

Gregory J. Gores, Maria Eugenia Guicciardi, Steven F. Bronk, Ariel E. Feldstein, Ali Canbay, Makiko Tanai, Hajime Higuchi, and Robert M. Rydzewski. 2003. “Cathepsin B Inactivation Attenuates Hepatic Injury and Fibrosis during Cholestasis.” Journal of Clinical Investigation 112 (July): 152–59. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7f1d49c2cc149fc8566845b257fca33&authtype=sso&custid=ns315887.